JoVE Logo

S'identifier

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.

A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of thiosulfate occurs through the transamination of β-cysteine to mercaptopyruvate.

Another significant phase II reaction involves conjugating endogenous purine and pyrimidine bases with ribose to create nucleotides. These nucleotides play a crucial role in protein synthesis and energy metabolism, highlighting the importance of this biotransformation process.

Finally, taurine, a β-amino sulphonic acid, contributes significantly to bile production. It conjugates with endogenous bile acids, adding to the composition of bile, which plays a pivotal role in digestion.

Phase II conjugation reactions neutralize harmful substances, support essential biological processes, and contribute to digestive functions, demonstrating their importance in maintaining overall health.

Tags

Phase II ReactionsBiotransformationsDetoxificationXenobioticsConjugationCyanide IonCellular RespirationRhodaneseThiosulfateThiocyanateNucleotidesProtein SynthesisEnergy MetabolismTaurineBile ProductionDigestion

Du chapitre 5:

article

Now Playing

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

39 Vues

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

341 Vues

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

233 Vues

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

142 Vues

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

63 Vues

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

174 Vues

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

73 Vues

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

156 Vues

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

273 Vues

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

167 Vues

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

141 Vues

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

175 Vues

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

132 Vues

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

183 Vues

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

107 Vues

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.